Botulinum toxin from Daewoong Pharmaceutical — who it suits, where it is used, and what it should cost
Quick answer
Nabota is a botulinum toxin from Daewoong Pharmaceutical (South Korea). It is a Korean type A toxin cleared by multiple regulators including the US FDA. Results typically last 3–4 months on the face and 4–6 months on the masseter. Reference pricing is about 7,000–12,000 บาท per 100 units in Thailand versus roughly 3,500–7,000 บาท per 100 units in Korea. The gap is wide, averaging roughly 40–50%. Registration: Thailand — Registered; Korea — Registered.
Nabota is the brand Thai visitors meet most often in Korea, because Gangnam clinics use it as the default in value packages. It has comparative data against the reference brand and clearance in strict markets, making it a rational pick for anyone not paying premium prices.
Technically, supplied in 100-unit vials, with head-to-head glabellar studies against the reference brand. That matters because it dictates how firm or soft the product feels, how far it spreads and which tissue plane it belongs in. Experienced injectors pick the sub-model to match the site rather than choosing on brand name alone.
Popular placement: forehead, glabella, crow's feet, masseter and calves. Good planning starts from a whole-face assessment rather than filling only the spot the patient points at, because balance comes from distributing volume sensibly, not from maximising one area.
On longevity, Nabota typically holds 3–4 months on the face and 4–6 months on the masseter. It fades sooner with a fast metabolism, frequent intense exercise, smoking, highly mobile areas such as lips and perioral skin, and under-dosing relative to what the face actually needs. It lasts longer with correct plane placement, a sub-model matched to local tissue pressure, and a top-up before the effect disappears completely.
Who it suits: people wanting a balance of price and evidence, and anyone treating in Korea where it is among the most widely used brands.
Not suitable or best avoided: anyone with prior toxin allergy or neuromuscular disease. This also covers pregnancy and breastfeeding, active infection at the injection site, and any known allergy to the product's components.
Thailand versus Korea: reference market pricing runs about 7,000–12,000 บาท per 100 units in Thailand and roughly 3,500–7,000 บาท per 100 units in Korea. The gap is wide, averaging roughly 40–50%. The honest comparison includes travel cost — flights, accommodation, interpreting and time. For a single small treatment the gap rarely covers a trip; combined with several procedures in one visit, the difference starts to matter.
The pitfall is cheap masseter packages that under-dose. A bulky masseter usually needs at least 25–35 units per side; paying less for 15 units per side typically produces a barely visible change and a second bill soon after.
Safety and authenticity: Very cheap promotions usually involve heavy dilution; ask how many real units you receive. Before treatment, ask to see the sealed box and label, check the registration number against Thailand's FDA or Korea's MFDS, photograph the lot number and expiry, and have the doctor open the product in front of you. A price far below market is usually a sign of unregistered stock or over-dilution.
Bottom line: Nabota is worth it when it is matched to a real concern, injected by a doctor who reads the whole face, and understood as a temporary result that needs maintenance rather than a one-off fix. Compare prices per unit or per cc of registered product — never a promotional price against a standard one.
Last updated: 2026-09-03 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.